News

Kroger Health, the healthcare division of The Kroger Co., has established its clinical trial site network in conjunction with Kroger's first trial in active recruitment for colorectal cancer gut and immune health observation.

Challenges and strategies for improving representation.

AARDEX Group’s MEMS® dosing capture and analytics system will be integrated with Cambridge Cognition’s Clinpal DCT platform.

Craig Coleman, PharmD, Professor at the University of Connecticut, and the Observational Study in Cancer-Associated Thrombosis for Rivaroxaban (OSCAR) study's principal investigator discusses the ins and outs of the study.

DCTs and RWD among topics for industry to focus on moving into 2023.

Medable's DCT platform selected by Nova Scotia Health to increase the accessibility of oncology care for remote patients in rural Nova Scotia.

Life science technology companies will create an integrated software solution to simplify clinical research activities and improve operational processes.

COTA joins consortium of biopharma companies, data sharing platforms, academic institutions, and service and technology partners.

Guide will help clinical regulators, biopharma, and healthcare organizations to implement the FAIR principles.

SolveBio's enterprise data management platform has integrated into QuartzBio's suite of SaaS solutions.

Introduces new platform which will reduce human error and accelerate trials.

EMA reminds the clinical trials community that the Clinical Trials Information System will be mandatory at the last day of this month.

National site network continues expansion, partners with Moderna on CMVictory Trial.

Strategic acquisition enables Tigermed to enhance its services in Europe.

The latest business and people happenings of the last month, all in one place.

THREAD will serve as the sole provider of DCTs and eCOA technology under new five-year collaboration.

New patient-reported outcome measure developed in collaboration with The Epilepsy Study Consortium.

Renewed interest in psychedelic research shows great promise for patients in need of more effective therapies.

New public benefit corporation seeks to unlock access to traditionally siloed data through RWD platform.

New index will score pharma companies on clinical trial diversity and appear in BMJ Medicine.

Study in collaboration with the Medical Research Council Epidemiology Unit at the University of Cambridge showed participants had high levels of engagement in remote COVID-19 study.

Market size expected to reach $1.96 million by 2030.

New South Korea office location part of APAC expansion plan for 2023.

Analysis shows breast cancer was the most extensively studied disease area in previous year.

Expands drug development and FDA regulatory expertise.

Deal takes the Phastar group to around 550 people worldwide and strengthens the company's position in Nordic region.

Combined Pinnacle and STRI platform expands network to six stand-alone sites.

Collaboration will aim to improve patient identification, stratification, recruitment, and enrollment in rare disease trials.